Physician profile
Eric D King
NPI 1700083409
$1,760.24
in general payments reported to CMS, 2019-2025
11 companies · $40.72 in 2025
The $40.72 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $298 · 2021: $1,297 · 2023: $60.29 · 2024: $64.13 · 2025: $40.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $165.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,366.55 | 2019-2025 | Mitraclip, Pressurewire |
| Cardinal Health 200 LLC | $163.18 | 2019 | |
| Edwards Lifesciences Corporation | $48.68 | 2019 | |
| Janssen Pharmaceuticals, INC | $45.96 | 2023 | Xarelto |
| Astrazeneca Pharmaceuticals Lp | $38.73 | 2023-2024 | Andexxa, Farxiga |
| Terumo Medical Corporation | $38.50 | 2019-2024 | Angio-Seal |
| Kestra Medical Technology Services, INC. | $22.71 | 2025 | Assure Wcd |
| Chiesi USA, INC. | $17.59 | 2019 | |
| Abiomed | $13.82 | 2019 | |
| Merit Medical Systems INC | $3.76 | 2024 | |
| Cardiovascular Systems INC. | $0.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.